Group 1 - Ningbo Physis Technology Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange on October 31, with CICC as the sole sponsor [1] - Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. also submitted a listing application, with Citigroup and Haitong International as joint sponsors [1] - Zhejiang Taotao Vehicles Co., Ltd. submitted a listing application, with CITIC Securities as the sole sponsor [1]

Group 1 - The company plans to acquire 100% equity of Jiangsu Langyan Life Science Technology Holdings Co., Ltd. through the issuance of shares and convertible bonds, while also raising matching funds from no more than 35 specific investors [3] - The company's stock was suspended from trading starting April 25, 2025, due to the planned asset acquisition and fundraising activities [3][4] - The stock is scheduled to resume trading on May 13, 2025, after the completion of relevant audits and evaluations [4] Group 2 - The board of directors has decided not to hold a shareholders' meeting to review the transaction until the audit and evaluation work is completed [4] - The company will continue to fulfill its information disclosure obligations in accordance with relevant laws and regulations after the stock resumes trading [4][5] - All information regarding the transaction will be disclosed through the Shanghai Stock Exchange website and designated media [5]